Time To Treatment Augmentation Among Patients With Chronic Obstructive Pulmonary Disease (COPD) Newly Initiated On Long Acting Muscarinic Agents (lama) Or Inhaled Corticosteroid (ics) And Long Acting Beta-2 Agonist (laba) Combination Therapy

被引：0
|
作者：
Patel, J. [1 ]
Mapel, D. W. [2 ]
Roberts, M. H. [2 ]
Sama, S. [3 ]
Gilmore, J. [3 ]
Sundaresan, D. [3 ]
Laliberte, F. [4 ]
Pilon, D. [5 ]
Lefebvre, P. [5 ]
Duh, M. [6 ]
机构：
[1] GlaxoSmithKline, Res Triangle Pk, NC USA
[2] Lovelace Clin Fdn, Albuquerque, NM USA
[3] Reliant Med Grp, Worcester, MA USA
[4] Grp Anal Ltee, Montreal, PQ, Canada
[5] Grp Anal Ltee, Montreal, PQ, Canada
[6] Anal Grp Inc, Boston, MA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5774
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease
    Welsh, Emma J.
    Cates, Christopher J.
    Poole, Phillippa
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):
  • [42] Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease
    Welsh, Emma J.
    Cates, Christopher J.
    Poole, Phillippa
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (05):
  • [43] Long-acting muscarinic antagonist and long-acting β2-agonist combination for the treatment of maintenance therapy-naïve patients with chronic obstructive pulmonary disease: a narrative review
    Buhl, Roland
    Miravitlles, Marc
    Anzueto, Antonio
    Brunton, Stephen
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2024, 18
  • [44] Long-acting muscarinic antagonist versus long-acting β2 agonist/corticosteroid for moderate to severe chronic obstructive pulmonary disease patients: Exacerbation risk assessment
    Yang, Sheau-Ning
    Ko, Hsin-Kuo
    Hsiao, Yi-Han
    Su, Kang-Cheng
    Chang, Yuh-Lih
    Huang, Hsin-Yi
    Perng, Diahn-Warng
    Chung, Mei-Ing
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (06) : 488 - 494
  • [45] Cost Effectiveness of the Long-Acting β2-Adrenergic Agonist (LABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LABA/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Obstructive Pulmonary Disease: Analyses Conducted for Canada, France, Italy, and Portugal
    M. Reza Maleki-Yazdi
    Mathieu Molimard
    Dorothy L. Keininger
    Jean-Bernard Gruenberger
    Joao Carrasco
    Claudia Pitotti
    Elsa Sauvage
    Sara Chehab
    David Price
    Applied Health Economics and Health Policy, 2016, 14 : 579 - 594
  • [46] Cost Effectiveness of the Long-Acting β2-Adrenergic Agonist (LABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LABA/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Obstructive Pulmonary Disease: Analyses Conducted for Canada, France, Italy, and Portugal
    Maleki-Yazdi, M. Reza
    Molimard, Mathieu
    Keininger, Dorothy L.
    Gruenberger, Jean-Bernard
    Carrasco, Joao
    Pitotti, Claudia
    Sauvage, Elsa
    Chehab, Sara
    Price, David
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2016, 14 (05) : 579 - 594
  • [47] APPROPRIATE USE OF INHALED CORTICOSTEROID AND LONG-ACTING β-AGONIST COMBINATION THERAPY AMONG ASTHMA PATIENTS
    Blanchette, C. M.
    Culler, S.
    Gutierrez, B.
    VALUE IN HEALTH, 2009, 12 (03) : A128 - A128
  • [48] Role of Tiotropium in Reducing Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients When Added to Long-Acting β2-Agonists (LABA) and Inhaled Corticosteroids (ICS)
    Belleudi, Valeria
    Ferroni, Eliana
    Agabiti, Nera
    Di Martino, Mirko
    Kirchmayer, Ursula
    Cascini, Silvia
    Bauleo, Lisa
    Pinnarelli, Luigi
    Patorno, Elisabetta
    Pistelli, Riccardo
    Formoso, Giulio
    Fusco, Danilo
    Davoli, Marina
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 33 - 34
  • [49] Adherence to Inhaled Corticosteroid (ICS) and Long Acting Beta-Adrenoceptor Agonist (LABA) Therapy in Severe Asthma Clinical Trials: A Systematic Review
    Mokoka, M. C.
    Mc Donnell, M. J.
    Cormican, S.
    Boland, F.
    Doyle, F.
    Costello, R. W.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : S455 - S455
  • [50] Long-acting muscarinic antagonist and long-acting beta 2-agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery
    Makino, Takashi
    Otsuka, Hajime
    Hata, Yoshinobu
    Koezuka, Satoshi
    Azuma, Yoko
    Isobe, Kazutoshi
    Sugino, Keishi
    Ebihara, Sitorlt
    Homma, Sakae
    Iyoda, Akira
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 8 (05) : 647 - 652
12345